Both brand-name and generic drugs must be approved by the Food and Drug Administration (FDA) before they can be prescribed to people. Brand-name drugs are marketed under exclusive, trademark-protected names and are protected by patents.

Medicare drug coverage (Part D) is extra coverage people with Medicare can choose to help lower costs of prescription drugs. Medicare-approved private plans offer this coverage. Even if you don’t take prescription drugs now, consider getting Medicare drug coverage.

helps cover the cost of prescription drugs. To get Medicare drug coverage, you must join a Medicare-approved plan that offers drug coverage. Private insurance companies offer Medicare drug coverage and must follow rules set by Medicare. Each plan can vary in …

Jan 17, 2025 · Medicare has selected 15 more drugs to negotiate directly with participating drug companies. Building on the success of the first round of negotiations, the aim is to lower prices for some more of the costliest prescription drugs.

Jul 6, 2023 · Broader Medicare coverage is now available for Biogen and Eisai’s Leqembi (the brand name for lecanemab) following the Food and Drug Administration’s (FDA) move to grant traditional approval to the drug that treats individuals with Alzheimer’s disease.

Jun 2, 2023 · In 2022, more than 3000 medical devices and diagnostics were introduced into the US health care system through the US Food and Drug Administration’s (FDA) Center for Devices and Radiological Health (CDRH). 1 Analysis of medical device development has often focused on timelines to FDA authorization. 2 Although achieving FDA authorization ...

This is amendment number one (1) to the Memorandum of Understanding (MOU) 225-10-0010 between the Food and Drug Administration and the Center for Medicare and Medicaid Services.

Better coordination between the FDA and CMS could improve the transparency and predictability of drug approval and coverage around accelerated-approval drugs, with important implications for patient outcomes, health spending, and evidence generation processes.

1 day ago · The Inflation Reduction Act of 2022 has triggered a raft of changes to Medicare Part D plans and Medicare Advantage plans that affect prescription drug coverage in 2025. Here’s what to know.

Mar 21, 2024 · Medicare could start covering Wegovy for certain senior citizens and other beneficiaries with a history of heart disease now that the US Food and Drug Administration has approved drugmaker...